Researchers at the Francis Crick Institute and Universidade de Santiago de Compostela have identified how the hepatitis B virus (HBV) can support the survival and growth of liver cancer, with this process starting early in ...
Nov 26, 2021
0
61
In 2015, University of Alberta cancer researcher Jack Tuszynski learned that his patent application for a promising chemotherapy treatment for people suffering from metastatic bladder cancer had been rejected by the U.S. ...
Nov 23, 2021
0
5
A government advisory committee on Wednesday recommended that all U.S. adults younger than 60 be vaccinated against hepatitis B, because progress against the liver-damaging disease has stalled.
Nov 3, 2021
0
49
The Pacific island nations are falling back on immunization targets, especially those for diseases spread through mother-to-child transmission, according to WHO officials.
Sep 27, 2021
0
0
Imagine it's 2030—and a typical day in a Nigerian healthcare setting. In earlier decades, when a patient walked in, they could see piles of folders and a clutter of pens scattered all over the office. They'd have a long ...
Jul 21, 2021
0
3
Vaccinations given in low- and middle-income countries (LMICs) in the last 20 years will prevent 50 million deaths from infectious diseases.
Jul 13, 2021
0
3
(HealthDay)—Health care providers should test liver recipients for hepatitis B virus (HBV) given the slight risk for unexpected donor-derived HBV infection, according to research published in the July 9 issue of the U.S. ...
Jul 12, 2021
0
0
The current system of only screening risk groups for hepatitis B is failing a third of people living with the chronic disease in Australia, according to the authors of a Perspective published today by the Medical Journal ...
Jun 14, 2021
0
3
While the risk of hepatocellular carcinoma (HCC) – primary liver cancer—is higher among patients who have HIV, it's even higher among patients who have HIV and detectable hepatitis B, according to research from the Perelman ...
May 21, 2021
0
10
Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.
May 14, 2021
0
22
